Ticker Scorecard - ESPR Basics Company: Esperion Therapeutics, Inc. IPO Date: June 26, 2013 Sector: Healthcare Industry: Biotech Market Cap: $306.93M Activated in VL: True Average Daily Range Avg Daily Range: $0.78 | 3.22% Avg Daily Range (30 D): $0.06 | 3.30% Avg Daily Range (90 D): $0.10 | 4.07% Institutional Daily Volume Avg Daily Volume: 1.4M Avg Daily Volume (30 D): 3.37M Avg Daily Volume (90 D): 5.21M Trade Size Avg Trade Size (Sh.): 192 Avg Trade Size (Sh.) (30 D): 451 Avg Trade Size (Sh.) (90 D): 446 Institutional Trades Total Inst.Trades: 2,934 Avg Inst. Trade: $1.8M Avg Inst. Trade (30 D): $.88M Avg Inst. Trade (90 D): $1.44M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.26M Avg Closing Trade (30 D): $.6M Avg Closing Trade (90 D): $1.05M Avg Closing Volume: 105.55K     News Mar 4, 2025 @ 11:00 AM Esperion Reports Fourth Quarter and Full Year 2024... Source: Esperion Therapeutics, Inc. Feb 18, 2025 @ 1:00 PM Esperion to Report Fourth Quarter and Full Year 20... Source: N/A Dec 18, 2024 @ 12:00 PM Esperion Strengthens Balance Sheet with Closing of... Source: N/A Dec 13, 2024 @ 11:00 AM Esperion Announces $210 Million Convertible Debt F... Source: Globe Newswire Dec 12, 2024 @ 1:00 PM Esperion Partners with Neopharm to Commercialize N... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.28 $-.11 $-.28 Diluted EPS $-.28 $-.11 $-.28 Revenue $ 332.31M $ 69.11M $ 332.31M Gross Profit $ $ $ Net Income / Loss $ -51.75M $ -21.32M $ -51.75M Operating Income / Loss $ 54.4M $ -4.42M $ 54.4M Cost of Revenue $ $ $ Net Cash Flow $ 62.51M $ .04M $ 62.51M PE Ratio     Splits Jun 11, 2013:   7:1